Emergent Biosolutions Inc

NYSE:EBS   3:59:55 PM EDT
-0.36 (-0.56%)
4:00:00 PM EDT: $63.28 -0.08 (-0.13%)

FDA Says Authorized Use For Janssen Covid-19 Vaccine Of Additional Batch Of Vaccine Drug Substance Manufactured At Emergent Facility

Published: 06/15/2021 22:52 GMT
Emergent Biosolutions Inc (EBS) - FDA Says Authorized Use, Under Eua for Janssen Covid-19 Vaccine, of Additional Batch of Vaccine Drug Substance Manufactured at Emergent Facility.
FDA Says Not Yet Ready to Include the Emergent Biosolutions Plant in Janssen Eua As an Authorized Manufacturing Facility.